Drug Approval | April 20, 2026
Aurobindo Pharma bags USFDA nod for Glycerol Phenylbutyrate Oral Liquid
The approved product is a generic version of Ravicti, originally developed and marketed by Horizon Therapeutics
The approved product is a generic version of Ravicti, originally developed and marketed by Horizon Therapeutics
Bolli will lead worldwide business development for the company’s Contract Development and Manufacturing Organisation (CDMO) services
Bajaj joins Health Prime after a long and progressive tenure at Concentrix
The launch coincides with IBS Awareness Month in April
Move to accelerate cancer care expansion across India
The investment will support the company’s plans to expand its network of specialised surgical hospitals across India.
The dispute stems from an earlier circular by Zuventus allegedly accusing Zorvia of market sabotage
The long-term exposure to fine particulate matter (PM2.5) increases overall cancer risk by 11%
Marking three years of the National Diagnostics Catapult (NDxC), the conclave launched the Impact Report and unveiled environmental surveillance kits
The drug is designed to provide temporary relief from cough caused by throat and bronchial irritation
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
